About PBS Biotech
PBS Biotech is a company based in Camarillo (United States) founded in 2006.. PBS Biotech has raised $70.21 million across 4 funding rounds from investors including Broadoak Capital Partners and Avego. PBS Biotech offers products and services including PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors. PBS Biotech operates in a competitive market with competitors including Limula, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others.
- Headquarter Camarillo, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pbs Biotech, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$70.21 M (USD)
in 4 rounds
-
Latest Funding Round
$17 M (USD), Series B
Jan 06, 2025
-
Investors
Broadoak Capital Partners
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PBS Biotech
PBS Biotech offers a comprehensive portfolio of products and services, including PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Small-scale single-use bioreactor for cell culture in therapy development
Mini bioreactor for scaling cell therapy processes and yields
Mid-scale bioreactor for advanced cell and gene therapy applications
Larger bioreactor for production-scale cell therapy manufacturing
High-capacity bioreactor for extensive cell therapy development
Unlock access to complete
Software Development Team
13 people
Advisor Team
12 people
Senior Team
5 people
Sales and Marketing
5 people
Service Team
2 people
Finance and Accounting
2 people
Leadership Team
2 people
Applications Team
2 people
Unlock access to complete
Funding Insights of PBS Biotech
PBS Biotech has successfully raised a total of $70.21M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $17 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $17.0M
-
First Round
First Round
(16 Aug 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series B - PBS Biotech | Valuation |
investors |
|
| Sep, 2024 | Amount | Series B - PBS Biotech | Valuation |
investors |
|
| Jan, 2023 | Amount | Series B - PBS Biotech | Valuation | Avego |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PBS Biotech
PBS Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Broadoak Capital Partners and Avego. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward the healthcare sector.
|
Founded Year | Domain | Location | |
|
Investment banking services are offered in the United States.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PBS Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PBS Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pbs Biotech Comparisons
Competitors of PBS Biotech
PBS Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Modular solutions for on-demand cell therapy manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for cell and gene therapies
|
|
| domain | founded_year | HQ Location |
Manufactures bioreactors, TFF systems, and software for biopharma and agri-food applications.
|
|
| domain | founded_year | HQ Location |
Contract research and discovery services are provided to biopharma firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pbs Biotech
Frequently Asked Questions about PBS Biotech
When was PBS Biotech founded?
PBS Biotech was founded in 2006 and raised its 1st funding round 15 years after it was founded.
Where is PBS Biotech located?
PBS Biotech is headquartered in Camarillo, United States. It is registered at Camarillo, California, United States.
Is PBS Biotech a funded company?
PBS Biotech is a funded company, having raised a total of $70.21M across 4 funding rounds to date. The company's 1st funding round was a Series B of $34.71M, raised on Aug 16, 2021.
What does PBS Biotech do?
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies. Their products include PBS MINI for early-stage process development, PBS 3 for laboratory RD applications, PBS 15 for laboratory RD and pre-clinical applications, PBS 80 for laboratory RD applications to clinical pilot production applications, PBS 500 for clinical and commercial production applications.
Who are the top competitors of PBS Biotech?
What products or services does PBS Biotech offer?
PBS Biotech offers PBS-0.1 Mini Bioreactors, PBS-0.5 Mini Bioreactors, PBS-3 Bioreactors, PBS-15 Bioreactors, and PBS-80 Bioreactors.
Who are PBS Biotech's investors?
PBS Biotech has 2 investors. Key investors include Broadoak Capital Partners, and Avego.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.